Stay updated with breaking news from Pulmonary Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pulmonx Corp (NASDAQ:LUNG), a company specializing in medical devices for the treatment of pulmonary disorders, has reported an insider sell according to a recent SEC filing.
NEW YORK, April 5, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Diet Pills Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product Type (Prescription
NEW YORK, Feb. 11, 2022 /PRNewswire/ -- Global demand for the gene delivery technologies market in 2020 was approximately USD 2,610.8 Million. The market is expected to grow at a CAGR of 15.3%